Sort
50,496 grants matching “lung cancer”
Pediatric Oncology Branch Behvioral Science Core
$1,051,746Melinda Merchant · Division Of Basic Sciences - Nci · ZID · FY2013 · CA
Novel bi-specific immunoprophylactics against multi-drug resistant Gram-negative bacterial infections
$1,051,346David S Perlin · Hackensack University Medical Center · R01 · FY2020 · AI
LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERS
$1,051,181Jenny T Mao · University Of California Los Angeles · U01 · FY2006 · CA
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
$1,050,989Debra L Friedman · Vanderbilt University Medical Center · UG3 · FY2022 · CA
Center for Interventional Oncology
$1,050,809Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2011 · CA
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
$1,050,779Joseph B. Margolick · Johns Hopkins University · U01 · FY2019 · HL
DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs
$1,050,726Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
$1,050,159Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership
$1,050,067Olorunseun O Ogunwobi · Hunter College · U54 · FY2018 · CA
Duke Cancer Health Disparities P20 SPORE
$1,050,058Steven R Patierno · Duke University · P20 · FY2022 · CA
SCH: Robust CT Colonography for Local & Cloud-Based Screening
$1,050,019Aly A Farag · University Of Louisville Research Foundation Inc · · FY2021 · CSE
Pre-clinical validation and verification of a biology-guided radiation therapy system
$1,050,000Samuel Mazin · Reflexion Medical, Inc. · R44 · FY2019 · CA
Precision microRNA medicine in cancer
$1,050,000Frank J. Slack · Beth Israel Deaconess Medical Center · R35 · FY2019 · CA
Precision microRNA medicine in cancer
$1,050,000Frank J. Slack · Beth Israel Deaconess Medical Center · R35 · FY2021 · CA
Precision microRNA medicine in cancer
$1,050,000Frank J. Slack · Beth Israel Deaconess Medical Center · R35 · FY2020 · CA
Precision microRNA medicine in cancer
$1,050,000Frank J. Slack · Beth Israel Deaconess Medical Center · R35 · FY2025 · CA
Patient tailored near real-time image-based treatment for interstitial PDT of Inoperable Cancer with Airway Obstruction - Phase IIa
$1,050,000Mary Potasek · Simphotek, Inc. · R44 · FY2021 · CA
NYU Lung Cancer Biomarker Center
$1,049,931William N Rom · New York University School Of Medicine · U01 · FY2006 · CA
A Novel Microbiome-Based Immune-Modulator that Potentiates Cancer Checkpoint Therapy
$1,049,717Gary Fanger · Rise Therapeutics, Llc · R44 · FY2022 · CA
Synthetic Approaches to Carcinogen-Linked Oligonucleotides
$1,048,822Carmelo J Rizzo · Vanderbilt University · P01 · FY2016 · CA
Synthetic Approaches to Carcinogen-Linked Oligonucleotides
$1,048,822Carmelo J Rizzo · Vanderbilt University · P01 · FY2015 · CA
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
$1,048,779Harold John Burstein · Dana-Farber Cancer Inst · UG1 · FY2025 · CA
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
$1,048,778Harold John Burstein · Dana-Farber Cancer Inst · UG1 · FY2024 · CA
IGF::OT::IGF CORE INFRASTURCTURE SUPPORT FOR SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS (SEER)PERIOD OF PERFORMANCE: 05/01/2015 TO 04/30/2016
$1,048,092Antoinette Stroup · Rbhs -Cancer Institute Of New Jersey · N01 · FY2015 · CA
Fred Hutchinson Breast Cancer Clinical Validation Center
$1,047,995Christopher I Li · Fred Hutchinson Cancer Center · U01 · FY2024 · CA